Literature DB >> 22753100

Myocardial perfusion imaging in coronary artery disease: SPECT, PET or CMR?

E E van der Wall1.   

Abstract

Entities:  

Year:  2012        PMID: 22753100      PMCID: PMC3402576          DOI: 10.1007/s12471-012-0300-z

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


× No keyword cloud information.
Noninvasive imaging in the evaluation of a wide variety of cardiovascular diseases has gained an increasing role in the diagnostic strategy in current cardiology practice [1-4]. This holds in particular for patients with myocardial ischaemia due to coronary artery disease (CAD) [5-7]. Of the present imaging modalities, single-photon emission computed tomography (SPECT), positron emission tomography (PET) and cardiac magnetic resonance (CMR) have attained a major position when it comes to myocardial perfusion imaging [8-12]. In the May 2012 issue of the Journal of the American College of Cardiology (JACC), Jaarsma et al. [13] from Maastricht University Medical Center evaluated the diagnostic accuracy of SPECT, PET and CMR for the diagnosis of obstructive CAD. Studies published between 1990 and 2010 identified by PubMed search and citation tracking were examined. A study was included if a perfusion imaging modality was used as a diagnostic test for the detection of obstructive CAD and coronary angiography as the reference standard (50 % diameter luminal stenosis). Out of a total of 3635 studies, 166 articles (including 17,901 patients) met the inclusion criteria: 114 SPECT, 37 CMR, and 15 PET studies. There were insufficient publications on perfusion echocardiography and computed tomography to include these modalities in the study. Patient-based analysis per imaging modality demonstrated pooled sensitivities of 88 % for SPECT, 84 % for PET , and 89 % for CMR; pooled specificities were 61 %, 81 %, and 76 %, respectively. The authors concluded that SPECT, PET, and CMR all yielded high sensitivities, whereas a broad range of specificities were observed. CMR and especially PET showed a significantly higher diagnostic accuracy than SPECT. However, SPECT is more widely available, less expensive, and most extensively validated. In addition, the use of attenuation programs improved the specificity of SPECT. CMR may provide a valid alternative without ionising radiation to the nuclear imaging methods. The authors suggested that referring physicians should consider these findings in the context of local expertise and internal logistics. The authors should be complimented for performing this impressive research. It is the first meta-analysis that has directly compared the three most commonly used techniques for myocardial perfusion imaging, i.e. SPECT, PET, and CMR. The present study emphasises that, from a clinical perspective, each of the studied imaging modalities is in principle suited for detection of abnormalities in myocardial perfusion imaging [14]. As always, selective use is mostly dependent on the institutional availability of the imaging device(s), familiarity with the technique, and the individual expert knowledge of the treating physician [15].
  15 in total

1.  Towards a noninvasive anatomical and functional diagnostic work-up of patients with suspected coronary artery disease.

Authors:  J G J Groothuis; A M Beek; M R Meijerink; S L Brinckman; M B M Hofman; A C van Rossum
Journal:  Neth Heart J       Date:  2010-05       Impact factor: 2.380

2.  Comparison of ultrafast dipyridamole magnetic resonance imaging with dipyridamole SestaMIBI SPECT for detection of perfusion abnormalities in patients with one-vessel coronary artery disease: assessment by quantitative model fitting.

Authors:  N A Matheijssen; H W Louwerenburg; F P van Rugge; R P Arens; B Kauer; A de Roos; E E van der Wall
Journal:  Magn Reson Med       Date:  1996-02       Impact factor: 4.668

3.  Cardiac magnetic resonance imaging in daily practice in a peripheral medical centre: description of the first 383 patients.

Authors:  C P H Lexis; B M Rahel; H van Langen; M A S Lexis; G A Hoffland; P J M Post; J G Meeder
Journal:  Neth Heart J       Date:  2010-11       Impact factor: 2.380

4.  Non-invasive visualization of the cardiac venous system in coronary artery disease patients using 64-slice computed tomography.

Authors:  Nico R Van de Veire; Joanne D Schuijf; Johan De Sutter; Dan Devos; Gabe B Bleeker; Albert de Roos; Ernst E van der Wall; Martin J Schalij; Jeroen J Bax
Journal:  J Am Coll Cardiol       Date:  2006-10-17       Impact factor: 24.094

5.  Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline.

Authors:  Gabe B Bleeker; Sjoerd A Mollema; Eduard R Holman; Nico Van de Veire; Claudia Ypenburg; Eric Boersma; Ernst E van der Wall; Martin J Schalij; Jeroen J Bax
Journal:  Circulation       Date:  2007-09-04       Impact factor: 29.690

Review 6.  Magnetic resonance imaging in coronary artery disease.

Authors:  E E van der Wall; H W Vliegen; A de Roos; A V Bruschke
Journal:  Circulation       Date:  1995-11-01       Impact factor: 29.690

7.  MR imaging of acute myocardial infarction: value of Gd-DTPA.

Authors:  A de Roos; J Doornbos; E E van der Wall; A E van Voorthuisen
Journal:  AJR Am J Roentgenol       Date:  1988-03       Impact factor: 3.959

8.  Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: a meta-analysis.

Authors:  Caroline Jaarsma; Tim Leiner; Sebastiaan C Bekkers; Harry J Crijns; Joachim E Wildberger; Eike Nagel; Patricia J Nelemans; Simon Schalla
Journal:  J Am Coll Cardiol       Date:  2012-05-08       Impact factor: 24.094

9.  Cardiac magnetic resonance imaging in stable ischaemic heart disease.

Authors:  S W Kirschbaum; P J de Feyter; R-J M van Geuns
Journal:  Neth Heart J       Date:  2011-05       Impact factor: 2.380

10.  Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability.

Authors:  M A G M Olimulder; M A Galjee; J van Es; L J Wagenaar; C von Birgelen
Journal:  Neth Heart J       Date:  2011-05       Impact factor: 2.380

View more
  3 in total

1.  Cost analysis favours SPECT over PET and CTA for evaluation of coronary artery disease: the SPARC study.

Authors:  E E van der Wall
Journal:  Neth Heart J       Date:  2014-06       Impact factor: 2.380

2.  Crown years for non-invasive cardiovascular imaging (Part II): 40 years of nuclear cardiology.

Authors:  E E van der Wall
Journal:  Neth Heart J       Date:  2013-05       Impact factor: 2.380

3.  Crown years for non-invasive cardiovascular imaging (Part III): 30 years cardiovascular magnetic resonance.

Authors:  E E van der Wall
Journal:  Neth Heart J       Date:  2013-06       Impact factor: 2.380

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.